Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Cancer Metastatic”

263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 263 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02657551
What this trial is testing

A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Dana-Farber Cancer Institute 8
Not applicableStudy completedNCT01103557
What this trial is testing

Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma

Who this might be right for
Thyroid NeoplasmLymphatic Metastasis
Pusan National University Hospital 62
Testing effectiveness (Phase 2)WithdrawnNCT02390739
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Who this might be right for
Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableNot Yet RecruitingNCT06725628
What this trial is testing

Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaLymph Node Cancer Metastatic
Tianhan Zhou 2,000
Post-approval studies (Phase 4)UnknownNCT04683575
What this trial is testing

Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma

Who this might be right for
Selenium DeficiencyThyroid Cancer TNM StagingRecurrence+1 more
Qianfoshan Hospital 5,000
Early research (Phase 1)Looking for participantsNCT03093909
What this trial is testing

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Who this might be right for
Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center 44
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Testing effectiveness (Phase 2)UnknownNCT04180007
What this trial is testing

Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

Who this might be right for
ThyroidMetastasisApatinib
Nanjing First Hospital, Nanjing Medical University 10
Not applicableLooking for participantsNCT07357571
What this trial is testing

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound

Who this might be right for
Thyroid Papillary CarcinomaContrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600
Early research (Phase 1)Ended earlyNCT03469011
What this trial is testing

Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
AHS Cancer Control Alberta 14
Early research (Phase 1)Study completedNCT01413113
What this trial is testing

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
University of Washington 6
Not applicableStudy completedNCT07115810
What this trial is testing

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

Who this might be right for
Differentiated Thyroid Cancer
King Faisal Specialist Hospital & Research Center 178
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Not applicableStudy completedNCT02268734
What this trial is testing

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Who this might be right for
Metastatic Sporadic Medullary Thyroid Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 36
Early research (Phase 1)Study completedNCT00673010
What this trial is testing

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 20
Not applicableStudy completedNCT00970359
What this trial is testing

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableUnknownNCT06241092
What this trial is testing

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 256
Load More Results